A multi-centre randomised phase II study of induction chemotherapy followed by gemcitabine or capecitabine based chemoradiotherapy (CRT) for locally advanced non-metastatic pancreatic cancer.
Phase of Trial: Phase II
Latest Information Update: 04 Apr 2017
At a glance
- Drugs Capecitabine (Primary) ; Gemcitabine (Primary) ; Gemcitabine (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Acronyms SCALOP
- 04 Apr 2017 Long-term results recurrence patterns, published in the British Journal of Cancer
- 03 Jun 2014 Results for health-related quality of life outcomes presented at the 50th Annual Meeting of the American Society of Clinical Oncology.
- 26 Jan 2013 Results presented at the 2013 Gastrointestinal Cancers Symposium.